Enter your login e-mail to the account
Search
Search parameters
Search results
- Current scientific knowledge about NAFLD/MAFLD during the COVID-19 pandemic and the benefits of essential phospholipids in the treatment of hepatic steatosis
doc. MUDr. Peter Minárik, PhD., MSc, prof. PharmDr. Ján Kyselovič, CSc., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Zuzana Paraličová, PhD., prof. MUDr. Peter Jarčuška, PhD.
(4/2022, Review articles ) - CYSTIC FIBROSIS
MUDr. Hana Kayserová
(3/2007, clearly ) - Liver cirrhosis – old but unbeaten disease
MUDr. Mária Belovičová, PhD.
(2/2009, Review articles ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - HIGH VIROLOGIC SUSTAINED RESPONSE TO FORMER YOUNG INTRAVENOUS DRUG ABUSERS WITH CHRONIC HEPATITIS C TREATED BY PEGYlATED INTERFERON – ALFA PLUS RIBAVIRIN (PRELIMINARY REPORT)
doc. MUDr. František Gazdík, doc. MUDr. Dušan Daniš CSc., RNDr. Kristína Fejdiová, MUDr. Michal Rastislav Piják, MUDr. Alexandra Mesárošová, MUDr. Ľubomír Okruhlica,, MUDr. Karol Laktiš, CSc., MUDr. Igor Stankovič, CSc., doc. MUDr. Katarína Gazdíková, PhD.
(10/2006, From practice ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Manažment pacientov s chronickou hepatitídou C s „normálnou“ aktivitou aminotransferáz
prof. MUDr. Ivan Schréter, CSc., MUDr. Peter Kristian
(4/2006, clearly ) - Advanced MRI methods for assessment of liver fibrosis and cirhosis
MUDr. René Hako, MUDr. Ivana Haková, doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Pavol Jarčuška, PhD.
(1/2015, Interdisciplinary consilium ) - Cystic fibrosis in adults
MUDr. Libor Fila, Ph.D.
(4/2015, Review articles ) - HEPATITIS C – NEWS IN THE TREATMENT
MUDr. Ľubomír Skladaný, PhD., MUDr. Elizabet Lovrantová
(5/2005, clearly ) - Effective drug therapy of liver diseases in general practice
doc. MUDr. Radan Brůha, CSc.
(1/2014, Review articles )
- Hepatocellular carcinoma from the radiologist's point of view
doc. MUDr. Viera Lehotská, PhD.
(4/2010, Review articles ) - Options of treatment for primary myelofibrosis with significant splenomegaly
MUDr. Kamil Diľ
(S2/2020, Case reports ) - Stereotactic body radiotherapy
doc. MUDr. Pavol Dubinský, PhD., MUDr. Martin Jasenčák
(2/2016, Main topic )
- N-acetylcysteine in current clinical praxis
MUDr. Jiří Slíva, Ph.D.
(3/2016, Drug profile ) - A role of N-acetylcysteine at present practice
doc. RNDr. Eva Račanská, CSc.
(3-4/2015, Information )
- Mesenchymal stromal cells in context of treatment of liver diseases
MUDr. Izabela Bosznayová, MUDr. Rastislav Kalanin, PhD., MUDr. Katarína Buzová, MUDr. Tomáš Gajdzik, PhD., MPH, doc. MUDr. Jana Kaťuchová, PhD., prof. MUDr. Jozef Radoňak, CSc., MPH
(2-3/2017, Review articles )